Client News

MS Pharma Becomes Partner for the Commercialization of FYB203, Formycon’s Biosimilar Candidate to Eylea® (Aflibercept), in the MENA Region

Medigene AG Extends Cash Runway into July 2025 After Successful Oversubscribed Capital Raise

Newron Reports Compelling Additional Data Documenting the Efficacy of Evenamide in Pivotal Study 008A in Poorly Responding Schizophrenia Patients

Volta Medical Featured in Latest Consensus Statement from Leading International Cardiac Electrophysiology Societies on Atrial Fibrillation Ablation

Medigene AG Successfully Raises approximately EUR 5.9 Million in Oversubscribed Capital Measure

InflaRx Reports First Quarter 2024 Financial Results and Provides Business Update

Abivax Announces Presentation of Four Abstracts for Obefazimod in Ulcerative Colitis and Preclinical Colon Cancer Model at Digestive Disease Week 2024

Formycon Reports on Successful Operating Business and Financial Figures for the First Quarter of 2024

Abivax Annual Ordinary and Extraordinary General Meeting of May 30, 2024 – Availability of the Preparatory Documents

Syntekabio to Showcase Biologics Discovery Platform at PEGS Boston